BioCryst Pharmaceuticals Competitors and Similar CompaniesClear all
BioCryst Pharmaceuticals's competitors and similar companies include Fortress Biotech, Bioiberica, Cellabs and Proteros.
 BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. |  Fortress Biotech Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. |  Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules. |  Cellabs Cellabs is a biotechnology company specializing in the design, development, and manufacture of immunodiagnostic kits for tropical and infectious diseases. | ||
Founding Date | Founding Date 1986 | Founding Date 2006 | Founding Date 1975 | Founding Date 1985 | Founding Date 2000 |
Type | Type Public | Type Public | Type Subsidiary | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Durham, US HQ Hoover, US | Locations New York, US HQ Waltham, US | Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES | Locations Brookvale, AU HQ | Locations Planegg, DE HQ Cambridge, US |
Employees | Employees 14040% increase | Employees 10146% decrease | Employees 332 | Employees N/A | Employees 147 |
Valuation ($) | Valuation ($) 1.7 b | Valuation ($) 55.7 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) $63.3m (FY, 2025) | Revenue (est.) $346.7m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $19.1m (FY, 2025) | Cost of goods $20.9m (FY, 2025) | Cost of goods $190.3m (FY, 2018) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $855.8m (FY, 2025) | Gross profit $42.3m (FY, 2025) | Gross profit $156.4m (FY, 2018) | Gross profit N/A | Gross profit N/A |
Net income | Net income $263.9m (FY, 2025) | Net income ($32.9m) (FY, 2025) | Net income $40.5m (FY, 2018) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 1.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 7m |
For sources of this data, please see the company profile
View Company Profiles
Fortress Biotech
HQ
New York, US
Employees
101↓ 46% decrease
Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.
View companyBioiberica
HQ
Esplugues de Llobregat, ES
Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
View companyCellabs
HQ
Brookvale, AU
Cellabs is a biotechnology company specializing in the design, development, and manufacture of immunodiagnostic kits for tropical and infectious diseases.
View company
Proteros
HQ
Planegg, DE
Proteros biostructures is a company that provides early-stage drug discovery services.
View company